174 related articles for article (PubMed ID: 26816662)
1. Association between Apolipoprotein C-III Gene Polymorphisms and Coronary Heart Disease: A Meta-analysis.
Zhang JZ; Xie X; Ma YT; Zheng YY; Yang YN; Li XM; Fu ZY; Dai CF; Zhang MM; Yin GT; Liu F; Chen BD; Gai MT
Aging Dis; 2016 Jan; 7(1):36-44. PubMed ID: 26816662
[TBL] [Abstract][Full Text] [Related]
2. Association between apolipoprotein C3 Sst I, T-455C, C-482T and C1100T polymorphisms and risk of coronary heart disease.
Lin B; Huang Y; Zhang M; Wang J; Wu Y
BMJ Open; 2014 Jan; 4(1):e004156. PubMed ID: 24430880
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein C3 gene variants and the risk of coronary heart disease: A meta-analysis.
Li Y; Li C; Gao J
Meta Gene; 2016 Sep; 9():104-9. PubMed ID: 27331014
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between apolipoprotein C3 gene polymorphisms and risk of coronary heart disease in a Han population in East China.
Yu J; Huang J; Liang Y; Qin B; He S; Xiao J; Wang H; Zhong R
Lipids Health Dis; 2011 Nov; 10():200. PubMed ID: 22054125
[TBL] [Abstract][Full Text] [Related]
5. Association between apolipoprotein B gene polymorphisms and the risk of coronary heart disease (CHD): an update meta-analysis.
Zhang JZ; Zheng YY; Yang YN; Li XM; Fu ZY; Dai CF; Liu F; Chen BD; Gai MT; Ma YT; Xie X
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):827-37. PubMed ID: 26537298
[TBL] [Abstract][Full Text] [Related]
6. Association of COX-2 -765G>C genetic polymorphism with coronary artery disease: a meta-analysis.
Zhang MM; Xie X; Ma YT; Zheng YY; Yang YN; Li XM; Fu ZY; Liu F; Chen BD
Int J Clin Exp Med; 2015; 8(5):7412-8. PubMed ID: 26221283
[TBL] [Abstract][Full Text] [Related]
7. APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome.
Miller M; Rhyne J; Chen H; Beach V; Ericson R; Luthra K; Dwivedi M; Misra A
Arch Med Res; 2007 May; 38(4):444-51. PubMed ID: 17416293
[TBL] [Abstract][Full Text] [Related]
8. APOA5 -1131T>C and APOC3 -455T>C polymorphisms are associated with an increased risk of coronary heart disease.
Sun Y; Zhou RB; Chen DM
Genet Mol Res; 2015 Dec; 14(4):18218-28. PubMed ID: 26782469
[TBL] [Abstract][Full Text] [Related]
9. Association between APOC3 polymorphisms and non-alcoholic fatty liver disease risk: a meta-analysis.
Wang J; Ye C; Fei S
Afr Health Sci; 2020 Dec; 20(4):1800-1808. PubMed ID: 34394242
[TBL] [Abstract][Full Text] [Related]
10. Heme oxygenase-1 gene promoter polymorphisms are associated with coronary heart disease and restenosis after percutaneous coronary intervention: a meta-analysis.
Zhang MM; Zheng YY; Gao Y; Zhang JZ; Liu F; Yang YN; Li XM; Ma YT; Xie X
Oncotarget; 2016 Dec; 7(50):83437-83450. PubMed ID: 27825138
[TBL] [Abstract][Full Text] [Related]
11. The impact of APOA5, APOB, APOC3 and ABCA1 gene polymorphisms on ischemic stroke: Evidence from a meta-analysis.
Au A; Griffiths LR; Irene L; Kooi CW; Wei LK
Atherosclerosis; 2017 Oct; 265():60-70. PubMed ID: 28865324
[TBL] [Abstract][Full Text] [Related]
12. Apo A5 -1131T/C, FgB -455G/A, -148C/T, and CETP TaqIB gene polymorphisms and coronary artery disease in the Chinese population: a meta-analysis of 15,055 subjects.
Li YY; Wu XY; Xu J; Qian Y; Zhou CW; Wang B
Mol Biol Rep; 2013 Feb; 40(2):1997-2014. PubMed ID: 23129316
[TBL] [Abstract][Full Text] [Related]
13. A PRISMA-compliant meta-analysis of apolipoprotein C3 polymorphisms and nonalcoholic fatty liver disease.
Chen BF; Chien Y; Tsai PH; Perng PC; Yang YP; Hsueh KC; Liu CH; Wang YH
J Chin Med Assoc; 2021 Oct; 84(10):923-929. PubMed ID: 34108427
[TBL] [Abstract][Full Text] [Related]
14. The effect of single nucleotide polymorphisms on depression in combination with coronary diseases: a systematic review and meta-analysis.
Zhang J; Gao L; Yang GL; Kong Z
Front Endocrinol (Lausanne); 2024; 15():1369676. PubMed ID: 38745947
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
[TBL] [Abstract][Full Text] [Related]
16. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.
Valenti L; Nobili V; Al-Serri A; Rametta R; Leathart JB; Zappa MA; Dongiovanni P; Fracanzani AL; Alterio A; Roviaro G; Daly AK; Fargion S; Day CP
J Hepatol; 2011 Dec; 55(6):1409-14. PubMed ID: 21777557
[TBL] [Abstract][Full Text] [Related]
17. Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease.
Dixit M; Choudhuri G; Saxena R; Mittal B
Can J Gastroenterol; 2007 Sep; 21(9):569-75. PubMed ID: 17853951
[TBL] [Abstract][Full Text] [Related]
18. Association of β2-adrenergic receptor gene polymorphisms (rs1042713, rs1042714, rs1042711) with asthma risk: a systematic review and updated meta-analysis.
Zhao S; Zhang W; Nie X
BMC Pulm Med; 2019 Nov; 19(1):202. PubMed ID: 31699066
[TBL] [Abstract][Full Text] [Related]
19. The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease.
Ding S; Liu L; Zhuge QC; Yu Z; Zhang X; Xie J; Hong W; Wang S; Yang Y; Chen B
Wien Klin Wochenschr; 2012 Oct; 124(19-20):671-7. PubMed ID: 22987045
[TBL] [Abstract][Full Text] [Related]
20. [Association between APOC3 promoter region polymorphisms and non-alcoholic fatty liver disease].
Niu T; Jiang M; Liu H; Jiang X; Lin Z; Zhang M; Wang J; Geng N; Xin Y; Xuan S
Zhonghua Gan Zang Bing Za Zhi; 2014 May; 22(5):374-9. PubMed ID: 25180874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
